Drug Development Market Scope And Analysis

  • Report Code : TIPRE00024322
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

2025 年至 2031 年药物开发市场预测及范围

Buy Now

Drug Development Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 9.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By 药物类型(小分子药物、生物药物)
    By 技术(高通量筛选、药物基因组学、组合化学、纳米技术、其他技术)
      By 最终用途(制药公司、合同研究组织、其他最终用户)
        By 地理(北美洲、欧洲、亚太地区、南美洲和中美洲、中东和非洲)
          Regions and Countries Covered North America
          • US
          • Canada
          • Mexico
          Europe
          • UK
          • Germany
          • France
          • Russia
          • Italy
          • Rest of Europe
          Asia-Pacific
          • China
          • India
          • Japan
          • Australia
          • Rest of Asia-Pacific
          South and Central America
          • Brazil
          • Argentina
          • Rest of South and Central America
          Middle East and Africa
          • South Africa
          • Saudi Arabia
          • UAE
          • Rest of Middle East and Africa
          Market leaders and key company profiles
        • Genome Biologics
        • Abbott Laboratories Inc.
        • Agilent Technologies Inc.
        • AstraZeneca PLC
        • AVIVA Biosciences
        • Bayer AG
        • Biotica Pharma.
        • Bristol-Myers Squibb Company
        • Collaborative Drug Discovery Inc.